Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Progeria pathophysiology
Introduction
Overview
Overview
It is thought that Hutchinson-Gilford progeria is the result due to mutation in LMNA gene.
Pathophysiology
Pathophysiology
Pathogenesis
- It is understood that Hutchinson-Gilford progeria is the result due to mutation in LMNA gene.[1]
Genetics
Genetics
Genes involved in the pathogenesis of Hutchinson-Gilford progeria syndrome (HGPS) include:[2]
LMNA Gene
Classic Hutchinson-Gilford progeria syndrome
- The location of the Hutchinson-Gilford progeria syndrome (HGPS) gene was at chromosome 1q.[3][4]
- A single nucleotide substitution in the lamin A/C gene LMNA(c.1824C>T [p.Gly608Gly]) results in classic HGPS.[5][6][7]
- The mutation does not change the position of glycine at 608 in protein chain.
- De novo dominant mutation in the LMNA gene causes classic HGPS.
- A single de novo dominant mutation at C to T pathogenic variant which is located at exon 11, C1824T of the LMNA gene results in activation of a cryptic splice donor site.[8]
- Now at cryptic splice donor site there is formation of a messenger RNA with a 150-nucleotide internal deletion near the C-terminus of the chain.
- The resultant of the mutation leads to formation of short lamin A protein which is called progerin.
- Progerin has a 50-amino acid internal deletion along with CAAX box farnesylation site due to de novo dominant mutation.
- Now the progerin which has 50-amino acid misses the cleave site, due to internal deletion which results in continuous farnesylation which in turn results in progerin anchored to the nuclear envelope.[9]
- This continuous farnesylation thought be the cause of the disease and results in following changes:
- Nuclear blebbing
- Disorganized heterochromatin
- Dysregulated gene transcription
- This whole unexpected sequences in the cell leads to genomic instability and may leads to premature aging and disease in Hutchinson-Gilford progeria syndrome.[10]
- And it is also thought that in Hutchinson-Gilford progeria syndrome telomere length is decreased gradually.[11]
Atypical progeria syndromes
- The cause of atypical progeria syndromes is almost similar to Classic Hutchinson-Gilford progeria syndrome except the mutations are mostly occurs in intron 11 of the LMNA gene where as in Classic Hutchinson-Gilford progeria the mutations occurs in c.1824C>T [p.Gly608Gly].[12][13]
References
References
- ↑ Pollex RL, Hegele RA (2004). “Hutchinson-Gilford progeria syndrome”. Clin Genet. 66 (5): 375–81. doi:10.1111/j.1399-0004.2004.00315.x. PMID 15479179.
- ↑ Pollex RL, Hegele RA (2004). “Hutchinson-Gilford progeria syndrome”. Clin Genet. 66 (5): 375–81. doi:10.1111/j.1399-0004.2004.00315.x. PMID 15479179.
- ↑ Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L; et al. (2003). “Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome”. Nature. 423 (6937): 293–8. doi:10.1038/nature01629. PMID 12714972.
- ↑ Decker ML, Chavez E, Vulto I, Lansdorp PM (2009). “Telomere length in Hutchinson-Gilford progeria syndrome”. Mech Ageing Dev. 130 (6): 377–83. doi:10.1016/j.mad.2009.03.001. PMID 19428457.
- ↑ Pollex RL, Hegele RA (2004). “Hutchinson-Gilford progeria syndrome”. Clin Genet. 66 (5): 375–81. doi:10.1111/j.1399-0004.2004.00315.x. PMID 15479179.
- ↑ Cao H, Hegele RA (2003). “LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090)”. J Hum Genet. 48 (5): 271–4. doi:10.1007/s10038-003-0025-3. PMID 12768443.
- ↑ Mazereeuw-Hautier J, Wilson LC, Mohammed S, Smallwood D, Shackleton S, Atherton DJ; et al. (2007). “Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature”. Br J Dermatol. 156 (6): 1308–14. doi:10.1111/j.1365-2133.2007.07897.x. PMID 17459035.
- ↑ Madej-Pilarczyk A (2006). “[Hutchinson-Gilford progeria in the light of contemporary genetics]”. Med Wieku Rozwoj. 10 (1 Pt 2): 355–62. PMID 17028399.
- ↑ Glynn MW, Glover TW (2005). “Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition”. Hum Mol Genet. 14 (20): 2959–69. doi:10.1093/hmg/ddi326. PMID 16126733.
- ↑ Csoka AB, English SB, Simkevich CP, Ginzinger DG, Butte AJ, Schatten GP; et al. (2004). “Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis”. Aging Cell. 3 (4): 235–43. doi:10.1111/j.1474-9728.2004.00105.x. PMID 15268757.
- ↑ Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB; et al. (1992). “Telomere length predicts replicative capacity of human fibroblasts”. Proc Natl Acad Sci U S A. 89 (21): 10114–8. doi:10.1073/pnas.89.21.10114. PMC 50288. PMID 1438199.
- ↑ Moulson CL, Fong LG, Gardner JM, Farber EA, Go G, Passariello A; et al. (2007). “Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes”. Hum Mutat. 28 (9): 882–9. doi:10.1002/humu.20536. PMID 17469202.
- ↑ Rivera-Torres J, Acín-Perez R, Cabezas-Sánchez P, Osorio FG, Gonzalez-Gómez C, Megias D; et al. (2013). “Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture”. J Proteomics. 91: 466–77. doi:10.1016/j.jprot.2013.08.008. PMID 23969228.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]